12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
周三盘中交易时段，12只医疗保健类股走势
Gainers
获胜者
- Stoke Therapeutics (NASDAQ:STOK) shares increased by 46.1% to $15.03 during Wednesday's regular session. The company's market cap stands at $671.1 million. As per the press release, Q4 earnings came out 2 days ago.
- Lixte Biotechnology (NASDAQ:LIXT) shares rose 43.68% to $3.24. The company's market cap stands at $7.2 million.
- Nuvation Bio (NYSE:NUVB) shares moved upwards by 35.41% to $3.9. The company's market cap stands at $854.2 million.
- Ontrak (NASDAQ:OTRK) shares moved upwards by 29.18% to $0.55. The market value of their outstanding shares is at $15.2 million.
- PAVmed (NASDAQ:PAVM) stock increased by 25.72% to $2.59. The market value of their outstanding shares is at $20.8 million. The company's, Q4 earnings came out yesterday.
- Nutriband (NASDAQ:NTRB) stock rose 24.33% to $3.78. The market value of their outstanding shares is at $31.9 million.
- Stoke Therapeutics（纳斯达克股票代码：STOK）股价在周三的例行交易中上涨了46.1％，至15.03美元。该公司的市值为6.711亿美元。根据新闻稿，第四季度收益在2天前公布。
- Lixte Biotechnology（纳斯达克股票代码：LIXT）股价上涨43.68％，至3.24美元。该公司的市值为720万美元。
- Nuvation Bio（纽约证券交易所代码：NUVB）股价上涨35.41％，至3.9美元。该公司的市值为8.542亿美元。
- Ontrak（纳斯达克股票代码：OTRK）股价上涨29.18％，至0.55美元。他们已发行股票的市值为1,520万美元。
- PAVMed（纳斯达克股票代码：PAVM）股价上涨25.72％，至2.59美元。他们已发行股票的市值为2,080万美元。该公司昨天公布了第四季度的收益。
- Nutriband（纳斯达克股票代码：NTRB）股价上涨24.33％，至3.78美元。他们已发行股票的市值为3190万美元。
Losers
失败者
- Akili (NASDAQ:AKLI) stock declined by 18.8% to $0.31 during Wednesday's regular session. The company's market cap stands at $24.3 million.
- Mesoblast (NASDAQ:MESO) shares declined by 12.85% to $3.42. The company's market cap stands at $347.5 million.
- Salarius Pharmaceuticals (NASDAQ:SLRX) stock fell 11.19% to $0.44. The company's market cap stands at $1.7 million. As per the news, the Q4 earnings report came out 3 days ago.
- XTL Biopharmaceuticals (NASDAQ:XTLB) shares fell 11.08% to $2.73. The market value of their outstanding shares is at $14.8 million.
- Fresh2 Group (NASDAQ:FRES) shares declined by 10.6% to $0.57. The market value of their outstanding shares is at $13.5 million.
- PDS Biotechnology (NASDAQ:PDSB) shares decreased by 9.94% to $4.04. The company's market cap stands at $125.5 million. As per the press release, Q4 earnings came out today.
- 周三的例行中，Akili（纳斯达克股票代码：AKLI）股价下跌18.8％，至0.31美元。该公司的市值为2430万美元。
- Mesoblast（纳斯达克股票代码：MESO）股价下跌12.85％，至3.42美元。该公司的市值为3.475亿美元。
- Salarius Pharmicals（纳斯达克股票代码：SLRX）股价下跌11.19％，至0.44美元。该公司的市值为170万美元。根据新闻，第四季度收益报告是在3天前发布的。
- XTL 生物制药（纳斯达克股票代码：XTLB）股价下跌11.08％，至2.73美元。他们已发行股票的市值为1480万美元。
- Fresh2集团（纳斯达克股票代码：FRES）股价下跌10.6％，至0.57美元。他们已发行股票的市值为1,350万美元。
- PDS生物技术（纳斯达克股票代码：PDSB）股价下跌9.94％，至4.04美元。该公司的市值为1.255亿美元。根据新闻稿，第四季度财报今天公布。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。